Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Varenicline for smoking cessation: A review of the literature.

Kaur K, Kaushal S, Chopra SC.

Curr Ther Res Clin Exp. 2009 Feb;70(1):35-54. doi: 10.1016/j.curtheres.2009.02.004. Erratum in: Curr Ther Res Clin Exp. 2010;71(1):89.

PMID:
24692831
[PubMed]
Free PMC Article
2.

Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence.

Hendrickson LM, Guildford MJ, Tapper AR.

Front Psychiatry. 2013 Apr 30;4:29. doi: 10.3389/fpsyt.2013.00029. eCollection 2013.

PMID:
23641218
[PubMed]
Free PMC Article
3.

Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study.

Ciani O, Buyse M, Garside R, Pavey T, Stein K, Sterne JA, Taylor RS.

BMJ. 2013 Jan 29;346:f457. doi: 10.1136/bmj.f457. Review.

PMID:
23360719
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cardiovascular effects of pharmacologic therapies for smoking cessation.

Sobieraj DM, White WB, Baker WL.

J Am Soc Hypertens. 2013 Jan-Feb;7(1):61-7. doi: 10.1016/j.jash.2012.11.003. Epub 2012 Dec 21. Review.

PMID:
23266101
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Therapeutic advances in the treatment of nicotine addiction: present and future.

Casella G, Caponnetto P, Polosa R.

Ther Adv Chronic Dis. 2010 May;1(3):95-106. doi: 10.1177/2040622310374896.

PMID:
23251732
[PubMed]
Free PMC Article
6.

Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.

Coffin PO, Santos GM, Das M, Santos DM, Huffaker S, Matheson T, Gasper J, Vittinghoff E, Colfax GN.

Addiction. 2013 Apr;108(4):751-61. doi: 10.1111/add.12073. Epub 2013 Jan 3.

PMID:
23186131
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Adherence to varenicline and abstinence rates for quitting smoking in a private health promotion center-based smoking cessation clinic.

Lee JY, Kim MJ, Jun HJ, Kang M, Park AR, Oh DE, Choi YH, Hwang JH.

Tuberc Respir Dis (Seoul). 2012 May;72(5):426-32. doi: 10.4046/trd.2012.72.5.426. Epub 2012 May 29.

PMID:
23101007
[PubMed]
Free PMC Article
8.

Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals.

Niaura R, Chander G, Hutton H, Stanton C.

Curr HIV/AIDS Rep. 2012 Dec;9(4):375-84. doi: 10.1007/s11904-012-0138-4. Review.

PMID:
22972495
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Weight gain in smokers after quitting cigarettes: meta-analysis.

Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P.

BMJ. 2012 Jul 10;345:e4439. doi: 10.1136/bmj.e4439.

PMID:
22782848
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Maintenance of reinforcement to address the chronic nature of drug addiction.

Silverman K, DeFulio A, Sigurdsson SO.

Prev Med. 2012 Nov;55 Suppl:S46-53. doi: 10.1016/j.ypmed.2012.03.013. Epub 2012 Jun 5.

PMID:
22668883
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.

Prochaska JJ, Hilton JF.

BMJ. 2012 May 4;344:e2856. doi: 10.1136/bmj.e2856. Review.

PMID:
22563098
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia.

Yousefi MK, Folsom TD, Fatemi SH.

J Addict Res Ther. 2011 Dec 20;S4(1). pii: 3045.

PMID:
22514788
[PubMed]
Free PMC Article
14.

Impact of varenicline on cue-specific craving assessed in the natural environment among treatment-seeking smokers.

Gass JC, Wray JM, Hawk LW, Mahoney MC, Tiffany ST.

Psychopharmacology (Berl). 2012 Sep;223(1):107-16. doi: 10.1007/s00213-012-2698-9. Epub 2012 Apr 4.

PMID:
22476610
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial.

Ferguson J, Docherty G, Bauld L, Lewis S, Lorgelly P, Boyd KA, McEwen A, Coleman T.

BMJ. 2012 Mar 23;344:e1696. doi: 10.1136/bmj.e1696.

PMID:
22446739
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial.

T√łnnesen P, Lauri H, Perfekt R, Mann K, Batra A.

Eur Respir J. 2012 Sep;40(3):548-54. doi: 10.1183/09031936.00155811. Epub 2012 Feb 9.

PMID:
22323576
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control.

Higgins GA, Silenieks LB, Rossmann A, Rizos Z, Noble K, Soko AD, Fletcher PJ.

Neuropsychopharmacology. 2012 Apr;37(5):1177-91. doi: 10.1038/npp.2011.303. Epub 2011 Dec 21.

PMID:
22189292
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Unannounced telephone pill counts for assessing varenicline adherence in a pilot clinical trial.

Thompson N, Nazir N, Cox LS, Faseru B, Goggin K, Ahluwalia JS, Nollen NL.

Patient Prefer Adherence. 2011;5:475-82. doi: 10.2147/PPA.S24023. Epub 2011 Sep 28.

PMID:
22003285
[PubMed]
Free PMC Article
19.

Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders.

Tiffany ST, Friedman L, Greenfield SF, Hasin DS, Jackson R.

Addiction. 2012 Apr;107(4):709-18. doi: 10.1111/j.1360-0443.2011.03581.x. Epub 2011 Oct 7.

PMID:
21981638
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Smoking cessation: an economic analysis and review of varenicline.

Faulkner MA.

Clinicoecon Outcomes Res. 2009;1:25-34. Epub 2009 Jun 24.

PMID:
21935304
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk